The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
October 29th 2024
The AI-enabled AutoChamber software also garnered the FDA’s breakthrough device designation for opportunistic detection of enlarged heart chambers on non-contrast CT scans.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Novel nuclear cardiac system nears market
November 27th 2007Spectrum Dynamics unveiled at the RSNA meeting the commercial version of its D-SPECT Cardiac gamma camera, which promises to cut the time typically needed to do a SPECT heart scan by 75% or more. Time savings come from solid-state cadmium-zinc-telluride detectors and proprietary image reconstruction techniques, according to the company.
Novel nuclear cardiac system nears market
October 26th 2007Next month Spectrum Dynamics will begin shipping its long-awaited D-SPECT Cardiac imaging product, featuring solid-state cadmium-zinc-telluride detectors and proprietary image reconstruction techniques that cut the time typically needed to do a SPECT heart scan by 75% or more. The Danville, CA-based company will target high-volume private cardiac labs and hospitals that put a premium on throughput and image quality.
Philips CFO deflects questions about RSNA unveilings
October 23rd 2007Digesting the mediocre performance by Philips Medical in the third quarter, financial analysts peppered Pierre-Jean Sivignon, chief financial officer of Koninklijke Philips Electronics, with questions about the company’s plans for the upcoming RSNA. They were looking for reasons to believe the CFO’s assertions that Philips’ financials would soon improve.
RadNet purchase paves way to strategic opportunities
October 23rd 2007The Deficit Reduction Act has undercut reimbursements for outpatient centers, ripening the market for consolidation -- and RadNet has been harvesting. The company last week acquired Liberty Pacific MRI of Encino for $2.8 million, the fourth California imaging center RadNet has bought in little more than a month.
Three-D measure of metabolism uses FDG to track response to mesothelioma therapy
October 18th 2007Patients with mesothelioma, a disease of the lung lining caused by exposure to asbestos, may someday benefit from a new 3D PET measure that helps accurately and quickly measure response to chemotherapy, according to a study published in the Journal of Nuclear Medicine.
Coronary CT angiography saves lives and money: 20,000-plus cases prove it
Questions remain from practitioners, payers, and administrators regarding the economic impact of coronary CT angiography on established diagnostic modalities and the effects on reimbursement within imaging. To address these concerns, we have developed the CCTA Data Registry, which now consists of more than 20,000 cases. Preliminary results indicate that coronary CTA is being utilized appropriately and affects savings for the healthcare system.